Published in Ann N Y Acad Sci on January 01, 1976
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol (1980) 1.13
Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes. Gut (1979) 0.91
Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease. Gut (1982) 0.85
Peripheral blood and mesenteric lymph node lymphocytes in Crohn's disease. Gut (1980) 0.84
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies. Clin Exp Immunol (1983) 0.77
Crohn disease. Newer aspects of etiology, diagnosis and therapy. West J Med (1978) 0.75
Influence of SRBC/lymphocyte ratio on T-cell rosettes in alcoholic liver disease and inflammatory bowel disease. Clin Exp Immunol (1977) 0.75
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Localization of A antigen sites on human erythrocyte ghosts. Nature (1971) 2.99
Purification of human monocytes on microexudate-coated surfaces. J Immunol (1978) 2.86
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med (1966) 2.63
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med (1966) 2.27
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods (1986) 2.16
The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol (1967) 2.03
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene (1995) 1.83
Myasthenia gravis. Lancet (1966) 1.82
The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol (1996) 1.75
Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest (1994) 1.70
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Management of Crohn's disease in adults. Am J Gastroenterol (1997) 1.65
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr (1982) 1.60
Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol (1972) 1.59
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr (1988) 1.57
Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology (1979) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant Rev (1972) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Human lymphocytes express substance P and its receptor. J Neuroimmunol (1998) 1.52
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Human lymphocyte growth in vitro: morphologic, biochemical, and immunologic significance. Int Rev Exp Pathol (1971) 1.45
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Perpetuation of published medical errors. Lancet (1993) 1.43
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42
Granulomatous ileocolitis. Gut (1966) 1.42
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
The use of 6-mercaptopurine in adolescents. Gastroenterology (1991) 1.40
Sera-reactivity in inflammatory bowel disease: frequency of recognition of Crohn's disease tissue primed nude mouse lymphoid tissue in an interinstitutional blinded study. J Clin Gastroenterol (1989) 1.40
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A (2001) 1.36
Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol (1992) 1.36
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. J Immunol Methods (1990) 1.27
Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Development of the premature infant's host defense system and its relationship to routine immunizations. Clin Perinatol (1984) 1.27